InChI=1S/C46H76NO10P/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 21- 23- 25- 27- 29- 31- 33- 35- 37- 44(48) 54- 39- 42(40- 55- 58(52,53) 56- 41- 43(47) 46(50) 51) 57- 45(49) 38- 36- 34- 32- 30- 28- 26- 24- 22- 20- 18- 16- 14- 12- 10- 8- 6- 4- 2/h11- 14,17- 20,23- 26,29,31,42- 43H,3- 10,15- 16,21- 22,27- 28,30,32- 41,47H2,1- 2H3,(H,50,51) (H,52,53) /b13- 11- ,14- 12- ,19- 17- ,20- 18- ,25- 23- ,26- 24- ,31- 29- /t42- ,43+/m1/s1 |
IEHVRLNIHFLLMS-WUDDRQCASA-N |
[H] [C@] (COP(OC[C@@] (COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC) =O) (OC(CCCCCC/C=C\C/C=C\C/C=C\CCCCC) =O) [H] ) (=O) O) (C(O) =O) N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via phosphatidyl-L-serine )
|
|
View more via ChEBI Ontology
(2S)- 2- amino- 3- ({hydroxy[(2R)- 3- [(5Z,8Z,11Z,14Z)- icosa- 5,8,11,14- tetraenoyloxy]- 2- [(8Z,11Z,14Z)- icosa- 8,11,14- trienoyloxy]propoxy]phosphoryl}oxy)propanoic acid
|
HMDB
|
1-Arachidonoyl-2-homo-g-linolenoyl-sn-glycero-3-phosphoserine
|
HMDB
|
1-Arachidonoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphoserine
|
HMDB
|
Phosphatidylserine(20:4/20:3)
|
HMDB
|
Phosphatidylserine(20:4n6/20:3n6)
|
HMDB
|
Phosphatidylserine(20:4w6/20:3w6)
|
HMDB
|
Phosphatidylserine(40:7)
|
HMDB
|
PS(20:4/20:3)
|
HMDB
|
PS(20:4n6/20:3n6)
|
HMDB
|
PS(20:4w6/20:3w6)
|
HMDB
|
PS(40:7)
|
HMDB
|
PSer(20:4/20:3)
|
HMDB
|
PSer(20:4n6/20:3n6)
|
HMDB
|
PSer(20:4w6/20:3w6)
|
HMDB
|
PSer(40:7)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|